MedTrace Logo

Effects of OCTA-guided PDT in Acute CSC

NCT03497000 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2018-04-17

No results posted yet for this study

Summary

OCTA-guided PDT is as safe and effective as ICGA-guided PDT in the treatment of acute central serous chorioretinopathy. Or OCTA-guided PDT is more effective than ICGA-guided PDT in the treatment of acute central serous chorioretinopathy, safe as well.

Conditions

  • Central Serous Chorioretinopathy
  • Tomography, Optical Coherence

Interventions

PROCEDURE

OCTA-guided Photodynamic therapy

Half-dose photodynamic therapy using verteporfin under the guidance of OCTA

PROCEDURE

ICGA-guided Photodynamic therapy

Half-dose photodynamic therapy using verteporfin under the guidance of ICGA

Sponsors & Collaborators

  • National Natural Science Foundation of China

    collaborator OTHER_GOV

  • Peking University People's Hospital

    lead OTHER

Principal Investigators

  • Mingwei Zhao, M.D · Peking University People's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2017-12-01
Completion
2018-03-27

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03497000 on ClinicalTrials.gov